Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis
- 14 May 2012
- journal article
- Published by Elsevier BV in Stem Cell Research
- Vol. 9 (2), 77-86
- https://doi.org/10.1016/j.scr.2012.05.001
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndromeBlood, 2009
- Protocols for Hematopoietic Stem Cell Expansion from Umbilical Cord BloodCell Transplantation, 2009
- Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignanciesCurrent Opinion in Oncology, 2009
- AKR‐501 (YM477) a novel orally‐active thrombopoietin receptor agonistEuropean Journal of Haematology, 2009
- Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor AgonistThe International Journal of Cell Cloning, 2009
- The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesisHaematologica, 2008
- Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic diseaseBlood, 2007
- Double Unrelated Reduced-Intensity Umbilical Cord Blood Transplantation in AdultsTransplantation and Cellular Therapy, 2007
- Stem Cell Transplantation (Cord Blood Transplants)Hematology, 2004
- Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioningBlood, 2003